Journal Guide

The Journal of Biochemical and Molecular Toxicology is an international journal that contains original research papers, rapid communications, mini-reviews, and book reviews, all focusing on the molecular mechanisms of action and detoxication of exogenous and endogenous chemicals and toxic agents. The scope includes effects on the organism at all stages of development, on organ systems, tissues, and cells as well as on enzymes, receptors, hormones, and genes. The biochemical and molecular aspects of uptake, transport, storage, excretion, lactivation and detoxication of drugs, agricultural, industrial and environmental chemicals, natural products and food additives are all subjects suitable for publication. Of particular interest are aspects of molecular biology related to biochemical toxicology. These include studies of the expression of genes related to detoxication and activation enzymes, toxicants with modes of action involving effects on nucleic acids, gene expression and protein synthesis, and the toxicity of products derived from biotechnology. Given the rapid development of the field of toxicology during the last few decades and the fundamental importance of biochemical mechanisms in all aspects of toxicology the Journal of Biochemical and Molecular Toxicology is of interest, not only to active investigators in the field but to many other scientists. These include other biochemists, molecular biologists, and toxicologists involved in industrial and contract research and testing laboratories, and those involved in legal and regulatory work related to toxic chemicals. The Journal of Biochemical and Molecular Toxicology is published bimonthly with one volume of 6 issues per calendar year.

Nanotechnology, dealing with functional structures and materials smaller than 100nm, is emerging as a truly interdisciplinary research area spanning several traditional scientific disciplines. In keeping with the growing trend, there is a strong need for a platform to share original research related to applications of nanotechnology in biomedical fields. In order to fulfill this demand, Journal of Biomedical Nanotechnology (JBN) is being created as an international peer-reviewed periodical that covers applications of nanotechnology in all fields of life sciences. JBN publishes original full papers and timely state-of-the-art reviews with author's photo and biography, and short communications encompassing the fundamental and applied research aspects. To speed up the reviewing process, we will provide on-line refereeing of all articles submitted in electronic form.

The Journal of Biomolecular Screening (JBS) is the leading peer-reviewed journal focusing on drug discovery sciences. JBS publishes information that enables researchers to evaluate current technologies and incorporate applications to enhance performance and objectives. Manuscripts and editorial commentary emphasize scientific and technical applications and advances in target identification/validation; lab automation and robotics; high-throughput screening (HTS); lead generation/optimization; virtual screening, chemoinformatics; diagnostic assays; assay development; assay technologies (novel applications, comparisons); data/image analysis, statistics and information technologies/methods; high content screening, imaging platforms; sample management (library design, compound logistics, chemical diversity); biological reagent production, characterization and management for drug discovery (cell lines, stem cells, surrogate tissues/species [xenopus, zebrafish, yeast]); genomic, proteomic screening; biomarkers; high throughput approaches to PK, ADME and predictive toxicology; legal, licensing issues.This publication will be of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: * drug, device, and biological research and development * drug screening and drug design * assessment of pharmacological activity * pharmaceutical formulation and scale-up * preclinical safety assessment * bioavailability, bioequivalence, and pharmacokinetics * phase, I, II, and III clinical development * premarket approval assessment of clinical safety * postmarketing surveillance Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

The Journal of Cardiovascular Pharmacology is the leading publication devoted exclusively to important advances in cardiovascular drug research and use. Each monthly issue provides the most up-to-date information on physiological and pharmacological bases of drug action, metabolism, drug interaction, side effects, and clinical results with both new and established drugs.Website: www.jcvp.org.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research.

JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

• Impact Factor: 3.062
• Authors receive a decision within 10 days, on average
• Fast OnlineFirst publication ahead of print

The Journal of Chemical Information and Modeling (JCIM) is a bi-weekly peer-reviewed journal that publishes papers reporting new methodologies in chemical informatics and molecular modeling and its application and validation by experimental means. As a member of this community – author, reader, or reviewer -- you’ll stay abreast of advances and applications in molecular simulation, developments in multi-scale modeling, artificial intelligence, and machine learning models applied to chemical and biological data, computer science techniques applied to chemical problems, pattern recognition, clustering, computer-aided molecular design of new materials, catalysts, or ligands, development of new computational methods and algorithms and their implementation in software, and analysis of chemical and physical data.

• Computer simulation using molecular dynamics and free energy methods
• Machine learning models of chemical and biological data
• Combined quantum mechanical/molecular mechanical (QM/MM) multi-scale simulations
• Computer-aided molecular design of new materials, catalysts, or ligands
• Development of new computational methods or efficient algorithms implemented in software
• Biopharmaceutical chemistry, including analyses of biological activity and other applications related to drug discovery 

The journal does not consider straightforward applications of molecular docking methods to a single target system without adequate experimental validation.

SUBSCRIBE TO THE Journal of Chemotherapyto help keep you up-to-date on antimicrobial chemotherapy,anticancer chemotherapy, immunomodulating chemotherapy,experimental and clinical studies in these fields published bimonthly.

The Journal of Computer-Aided Molecular Design provides a form for disseminating information on both the theory and the application of computer-based methods in the analysis and design of molecules. The scope of the journal encompasses papers which report new and original research and applications in the following areas: theoretical chemistry;
computational chemistry;
computer and molecular graphics;
molecular modeling;
protein engineering;
drug design;
expert systems;
general structure-property relationships;
molecular dynamics;
chemical database development and usage. Contributions on computer-aided molecular modeling studies in pharmaceutical, polymer, materials and surface sciences, as well as other molecular-based disciplines, are particularly welcome.

As of Volume 15, a number of issues per volume will be dedicated to Perspectives in Drug Discovery and Design and from time to time overviews will be included in `regular' JCAMD issues. Perspectives in Drug Dis

The Journal of Controlled Release publishes high-quality research from and for pharmaceutical and biomaterials scientists in academia and industry on drug delivery, including drug biological properties of drugs, drug release mechanisms, drug delivery routes, drug delivery vehicles, bioactive polymers and hydrogels for drug delivery, delivery approaches, tissue engineering, and molecular imaging. Each issue has gene delivery and nanomedicine sections along with the cover story.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

READ the journal http://www.sciencedirect.com/science/journal/17732247HERE

The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed.

ournal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.Journal of Drug Targeting also carries papers on the physiological and other biological barriers to delivery and targeting, and means of overcoming the barriers, for example, by penetration enhancers, and covers subjects such as extravasation, diffusion in tumours and target tissues, avoidance of the reticulo-endothelial system, and toxicity testing and licensing of novel delivery systems.The Journal’s life-time achievement award winners to date are: 2009: PP Speiser (Switzerland), 2008: G Gregoriadis (UK), 2007: H Maeda (Japan), 2006: H Ringsdorf (Germany), 2005: A T Florence (UK), 2004: R L Juliano (USA)Read More: http://informahealthcare.com/page/drt/Description.

Journal of Environmental Biology is a broad-based, peer-reviewed, leading International Journal, and publishes original research papers dealing with all aspects of Environmental Sciences, Environmental Engineering, Environmental Pollution, Environmental Biotechnology, Toxicology, Forestry and related fields -- in English language.

The Journal of Environmental Pathology, Toxicology and Oncology publishes original research and reviews of factors and conditions that affect human and animal carcinogensis. Scientists in various fields of biological research, such as toxicologists, chemists, immunologists, pharmacologists, oncologists, pneumologists, and industrial technologists, will find this journal useful in their research on the interface between the environment, humans, and animals.

Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

Journal of Enzyme Inhibition and Medicinal Chemistry is an international and interdisciplinary vehicle publishing new knowledge and findings on enzyme inhibitors and inhibitory processes and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents and an understanding of their action.The Journal will publish research papers, short communications and reviews on current developments in enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology leading to drug design, molecular recognition processes and distribution and metabolism of biologically active compounds. Among the various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.Read More: http://informahealthcare.com/page/enz/Description.